false
Hamburger Menu
Catalog
Understanding KRAS G12C in NSCLC
Understanding KRAS G12C in NSCLC
Podcast | English | 2021 | 33 Min
Create Account
Credit
No Credit Offered
Summary
This episode of Lung Cancer Considered covers recent promising results with new targeted agents for NSCLC harboring a KRAS G12C mutation. Thoracic oncologists have long thought this condition was undruggable, but results presented at WCLC 2020 from the CodeBreak 100 trial provide hope that new therapies will be more readily available.
Faculty
Dr. Tetsuya Mitsudomi
×
Understanding KRAS G12C in NSCLC Course List
Login
User Login
Continue with Google
OR
Email
Password
Logging In…
Create Account
Forgot Password
×
Please select your language
1
English